论文部分内容阅读
目的分析抗肿瘤药物不良反应情况,为临床合理用药提供参考。方法选取100例行常规抗肿瘤药物治疗的肿瘤患者,患者均进行体质检测,观察患者出现的不良反应情况。结果 100例患者在经抗肿瘤药物治疗后,出现的不良反应主要为心脏毒性(5%)、泌尿系统毒性(12%)、血液系统毒性(15%)以及消化系统功能异常(62%),且上述患者中出现重度并发症患者14例,不良反应率为14%。结论对肿瘤患者进行抗肿瘤药物治疗时,患者均出现不用程度的不良反应,在临床治疗过程中,对于抗肿瘤药物选取时,应该以患者的承受能力作为参考,才能使患者抗肿瘤的治疗效果达到最佳。
Objective To analyze the adverse reactions of antitumor drugs and provide reference for clinical rational drug use. Methods Totally 100 cancer patients who underwent routine antitumor drug therapy were selected for physical examination. The adverse reactions of the patients were observed. Results 100 patients were mainly treated with anti-tumor drugs. The main adverse reactions were cardiotoxicity (5%), urinary system toxicity (12%), hematological toxicity (15%) and digestive system dysfunction (62% Among the above patients, 14 patients had severe complications, the rate of adverse reactions was 14%. Conclusion In the treatment of cancer patients with antineoplastic drugs, the patients showed unnecessary degree of adverse reactions in the clinical course of treatment, the selection of anti-tumor drugs should be based on the patient’s ability as a reference in order to make the patient’s anti-tumor effect Reach the best.